2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Laryngeal Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Warts
1
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Retinoblastoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papillomavirus Infections
1
Papilloma
1
Pain
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
40
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
32
Papillomavirus Vaccines
24
Human Papillomavirus Recombinant Vaccine nonavalent
12
Vaccines
11
Blood Specimen Collection
10
Data Collection
9
Colposcopy
9
Human Papillomavirus DNA Tests
8
Specimen Handling
7
Radiotherapy, Intensity-Modulated
7
Cisplatin
7
Surveys and Questionnaires
6
Educational Status
6
Early Intervention, Educational
6
Carboplatin
6
Vaginal Smears
5
Vaccines, Synthetic
5
Methods
5
Engerix-B
4
fludarabine
3
epigallocatechin gallate
3
artesunic acid
3
artemisinin
3
Watchful Waiting
3
Polymerase Chain Reaction
3
Patient Navigation
3
Paclitaxel
3
Observation
3
Mass Screening
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts